Diagnosis and treatment of coincident vesical transitional cell carcinoma and prostate cancer: a report of 5 cases / 中华男科学杂志
National Journal of Andrology
; (12): 44-47, 2010.
Article
en Zh
| WPRIM
| ID: wpr-252875
Biblioteca responsable:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To improve the diagnosis and treatment of coincident vesical transitional cell carcinoma (VTCC) and prostate cancer.</p><p><b>METHODS</b>We analyzed the clinical data of 5 cases of coincident VTCC and prostate cancer.</p><p><b>RESULTS</b>The 5 patients, at the mean age of 66.2 years, were diagnosed as having grade II - III VTCC by cystoscopy and biopsy, 1 with a history of prostate cancer, and the other 4 with prostate cancer confirmed by postoperative pathological examination. Two of the patients were treated by radical cystoprostatectomy, 1 by radical cystoprostatectomy and ileum conduit surgery, 1 by transurethral resection of bladder tumor, and the other 1 by palliative ureterocutaneostomy due to cardiopulmonary problems. The follow-up lasted 8 -26 months. One of them died of diffused metastasis 20 months after surgery, 1 survived with the tumor untreated, and the other 3 remained tumor free.</p><p><b>CONCLUSION</b>Coincident VTCC and prostate cancer is easy to be missed in diagnosis. PSA detection, rectal palpation, transrectal ultrasonography, biopsy, and cystoscopy are the main diagnostic options for this disease. Its treatment should be based on the classification and clinical staging of the two cancers. Coincident VTCC and prostate cancer does not suggest poor prognosis.</p>
Texto completo:
1
Banco de datos:
WPRIM
Asunto principal:
Patología
/
Pronóstico
/
Neoplasias de la Próstata
/
Cirugía General
/
Neoplasias de la Vejiga Urinaria
/
Carcinoma de Células Transicionales
/
Diagnóstico
/
Estadificación de Neoplasias
Tipo de estudio:
Diagnostic_studies
/
Prognostic_studies
Límite:
Aged
/
Humans
/
Male
Idioma:
Zh
Año:
2010
Tipo del documento:
Article